NCT06922903: Phase III Clinical Trial to Evaluate INR101 Injection for PET/CT Imaging in Patients With Prostate Cancer.
- State
- Not started
- Phase
- Phase 3
- People
- 240 planned
- Started
- Apr 2025
- Primary completion
- May 2026
- Arms
- INR101 PET/ CT
- Results
- None posted
- 11 Apr 2025: Trial registered